The Korean Supreme Court’s recent decision clarified the patentability of dosage regimen inventions, emphasizing the requirement for quantitatively remarkable or qualitatively different effects, setting a key legal precedent in Korea.
ARTICLES & NEWS
Supreme Court rules that dosage regime is inventive
